SpaceX’s, Billion

SpaceX’s $60 Billion Cursor Acquisition and $25 Billion Bond Fuel Volatility as Key July 7 Date Approaches

04.07.2026 - 01:31:55 | boerse-global.de

SpaceX shares plummet from $225 high to $158 amid a dilutive $60B acquisition, $25B bond issue, and mixed analyst outlooks ahead of Nasdaq-100 inclusion.

SpaceX Stock Crashes After IPO: Dilution, Debt, and Analyst Split
SpaceX’s - SpaceX’s $60 Billion Cursor Acquisition and $25 Billion Bond Fuel Volatility as Key July 7 Date Approaches 04.07.2026 - Bild: über boerse-global.de

SpaceX’s post-IPO honeymoon has been brutally brief. The stock debuted at $150 on June 12, skyrocketed to an all-time high above $225 within days, and has since collapsed back to roughly $158 — barely above the offer price. The culprit? A toxic cocktail of structural scarcity, a dilutive mega-acquisition, and a sudden thirst for debt.

The space giant floated just 4.24% of its total equity in the IPO, creating a classic demand-overhang squeeze. That tiny float met an avalanche of buyer enthusiasm, sending the stock into orbit far beyond any fundamental anchor. But gravity returned quickly when SpaceX announced it would acquire Cursor for $60 billion, paid for entirely in its own shares. The massive dilution spooked investors, and the selling snowballed. Additional pressure arrived on June 22 with the unveiling of a $25 billion bond issue, sending the stock down more than 12% in a single session.

All eyes are now on Tuesday, July 7, when two critical milestones collide. That day, SpaceX will be added to the Nasdaq-100 index, forcing index funds and ETFs to buy the stock — a potential short-term tailwind. At the same time, the official quiet period for the IPO’s underwriting banks ends, unleashing a wave of institutional research that has been locked up since the listing. Independent analysts have already broken their silence, and their opinions are wildly divergent.

Should investors sell immediately? Or is it worth buying SpaceX?

Daiwa initiated coverage with a neutral rating and a $175 price target, while the firm Kailash Concepts warned of severe downside risk, noting that SpaceX trades at roughly 100 times annual revenue — a multiple that, historically, almost always leads to underperformance. On the bullish side, Arete Research’s Andrew Beale slapped a $401 target and a buy rating, arguing the market underestimates the Starship rocket and Starlink V3 satellites. Wedbush joined the optimists with an outperform rating and $190 target. The consensus average sits near $188, with seven of eight analysts recommending buys and just one sell.

The options market is reflecting extreme positioning. Nearly one million contracts have changed hands recently, generating over $1.4 billion in premiums — volume almost matching Nvidia. The stock itself is oscillating around $158, well off the June high of $225.64 but still above the post-IPO low of $147.11.

Beyond the July 7 events, the next major catalyst is the first quarterly earnings report in August. Shortly thereafter, insider lockup restrictions begin to ease. Executives will be permitted to sell up to 20% of their restricted shares, and if the stock is trading above $175.50 at that time, an additional 10% tranche unlocks. The result will be a significant increase in the public float — and a real test of whether SpaceX’s valuation can hold.

Ad

SpaceX Stock: New Analysis - 4 July

Fresh SpaceX information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated SpaceX analysis...

en | US84615Q1031 | SPACEX’S | boerse | 69683547 |